Immunization of avians by administration of non-replicating vectored vaccines
US10744195B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 28, 2017 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | Nov 28, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the invention relates to recombinant human adenovirus vectors for delivery of avian immunogens and antigens, such as avian influenza into avians. The invention also provides methods of introducing and expressing an avian immunogen in avian subjects, including avian embryos, as well as methods of eliciting an immunogenic response in avian subjects to avian immunogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.